I lead the global vision for Menarini Stemline’s patient advocacy programs by building alliances with key advocacy, medical, and scientific leaders to gather insights into the unmet needs of people living with cancer. These insights provide direction and opportunity for engaging with patient communities. They also help to guide the company's processes and therapeutics development to improve people's lives.• Ensure the patient voice is included in all aspects of our research and drug… Show more I lead the global vision for Menarini Stemline’s patient advocacy programs by building alliances with key advocacy, medical, and scientific leaders to gather insights into the unmet needs of people living with cancer. These insights provide direction and opportunity for engaging with patient communities. They also help to guide the company's processes and therapeutics development to improve people's lives.• Ensure the patient voice is included in all aspects of our research and drug development programs• Support educational programming and resources to identify and address the unmet needs of the community• Cultivates long-term strategic partnerships with leaders in the patient community, including advocacy groups, medical and scientific leaders, clinical specialists, societies, collaborative groups, and other external partners • Works cross-functionally, developing and implementing strategies to achieve advocacy, in line with medical, regulatory, and corporate objectives • Drives successful stakeholder working teams, proactively identifying emerging issues, and effectively communicating Menarini Stemline’s positions on relevant public health, economic, clinical, and political issues to key non-government stakeholders Show less

Relationship building and liaison activities to share important data, identify research interests and foster scientific collaborations with key influential hematologists, oncologists and healthcare provider team members. Support development and applications of Menarini/Stemline products aligned with corporate goals to improve cancer patient outcomes and their quality of life. • Provide information and promote data exchange with KOLs regarding Stemline’s oncology portfolio for approved… Show more Relationship building and liaison activities to share important data, identify research interests and foster scientific collaborations with key influential hematologists, oncologists and healthcare provider team members. Support development and applications of Menarini/Stemline products aligned with corporate goals to improve cancer patient outcomes and their quality of life. • Provide information and promote data exchange with KOLs regarding Stemline’s oncology portfolio for approved and pipeline products. • Participate in key oncology national conferences and regional meetings to engage experts and raise awareness for Stemline’s CD123+ targeted indications. • Generate interest with KOLs to support investigator initiated and company sponsored clinical trials to expand indications for Stemline’s products and pipeline. Show less

Patient Advocacy, Health Coaching and Patient Navigation services for oncology and rare disease patients to educate and facilitate access to therapy.

Providers of Patient Advocacy resources to pharmaceutical companies specializing in oncology and rare diseases. Consulting services focused on the development of mutually beneficial relationships between pharmaceutical companies and the patient communities they serve.• Advocacy landscape analysis and mapping• Advocacy strategic plan development and mentoring support• Patient Advisory Boards• Patient Journey• Patient Stories• Corporate engagement in disease state… Show more Providers of Patient Advocacy resources to pharmaceutical companies specializing in oncology and rare diseases. Consulting services focused on the development of mutually beneficial relationships between pharmaceutical companies and the patient communities they serve.• Advocacy landscape analysis and mapping• Advocacy strategic plan development and mentoring support• Patient Advisory Boards• Patient Journey• Patient Stories• Corporate engagement in disease state education and volunteer work• Social media AI Show less

Created and directed Aeglea’s Patient Advocacy Program with the Inborn Error of Metabolism (IEM) Community. Developed relationships and collaborations with patients, their families and health care professional stakeholders. Activities included:• Define the natural history, standards of care and health resources with IEM Key Opinion Leaders (KOLs) for a very rare pediatric disorder, Arginase Deficiency. • Build a community and provide resources for IEM patients and health care… Show more Created and directed Aeglea’s Patient Advocacy Program with the Inborn Error of Metabolism (IEM) Community. Developed relationships and collaborations with patients, their families and health care professional stakeholders. Activities included:• Define the natural history, standards of care and health resources with IEM Key Opinion Leaders (KOLs) for a very rare pediatric disorder, Arginase Deficiency. • Build a community and provide resources for IEM patients and health care professionals to support the needs of the patient community and patient participation in clinical trials of AEB1102 and future compounds targeting inborn errors of metabolism.• Guide and maintain the Aegela interface between KOLs, advocacy, and patient communities in support of clinical development efforts and internal key members of Aeglea senior management, clinical, and development teams to better understand and impact the patient communities unmet needs.• Develop and publish research initiatives with KOLs, modeling a patient-centric approach to drug development and a greater understanding about the natural history, disease burden, screening guidelines and the patient journey of Arginase Deficiency patients. Show less

Developed and implemented post launch Medical Affairs strategy• Identified and cultivated relationships with key opinion leaders in Hepatic and Gastrointestinal malignancies.• Acted as a liaison with key oncologists and within CeloNova departments/business unit to refine strategy and improvement to the existing Investigator Sponsored Trial program.• Provided onsite Oncozene microsphere education and training to field investigators to support good clinical practice and… Show more Developed and implemented post launch Medical Affairs strategy• Identified and cultivated relationships with key opinion leaders in Hepatic and Gastrointestinal malignancies.• Acted as a liaison with key oncologists and within CeloNova departments/business unit to refine strategy and improvement to the existing Investigator Sponsored Trial program.• Provided onsite Oncozene microsphere education and training to field investigators to support good clinical practice and appropriate product use. Show less

Implemented Pre-Launch Medical Affairs strategy• Successfully made personal contact with >200 Oncology Key Opinion Leaders (KOLs) to support pre-launch Marqibo product and company awareness program exceeding plan objectives. • Supported cross functional product team in pre-launch activities, data dissemination and education for Talon/Marqibo activities at ASH 2012.

Consultant, Senior Director, Investigator Sponsored Trials Directed and implemented the Ibrutinib (PCI 32765) Investigator Sponsored Trials (IST) program, activating 6 trials in 9 months with Key Opinion Leaders (KOLs): • Cultivated relationships and initiatives with KOLs to support investigator-sponsored research in alignment with corporate research and product plans. • Created Investigator Sponsored Trial (IST) program standard operating procedures including clinical… Show more Consultant, Senior Director, Investigator Sponsored Trials Directed and implemented the Ibrutinib (PCI 32765) Investigator Sponsored Trials (IST) program, activating 6 trials in 9 months with Key Opinion Leaders (KOLs): • Cultivated relationships and initiatives with KOLs to support investigator-sponsored research in alignment with corporate research and product plans. • Created Investigator Sponsored Trial (IST) program standard operating procedures including clinical trial review board, study implementation, national study tracking and budgetary accountability parameters for US program ensuring scientific merit, regulatory compliance, and financial responsibility.• Developed “open access” data monitoring system for Medical Science Liaison (MSL) IST program using Sharepoint. Show less

Identified and built relationships with national KOLs at major institutions in support of Continuing Medical Education (CME) development and sales programs:• Generated strategic plans to provide needs-based, educational programs targeting clinical practice gaps, KOL interests and pharmaceutical sponsors’ CME program and grant criteria.• Validated key oncology education issues with data from two online national surveys that identified physician- specified educational needs… Show more Identified and built relationships with national KOLs at major institutions in support of Continuing Medical Education (CME) development and sales programs:• Generated strategic plans to provide needs-based, educational programs targeting clinical practice gaps, KOL interests and pharmaceutical sponsors’ CME program and grant criteria.• Validated key oncology education issues with data from two online national surveys that identified physician- specified educational needs. - Cancer Clinical Trial Destination -Dr. M. Markman/MD Anderson Cancer Center - Survivorship Health Initiative-Mary McCabe, MSN/ Memorial Sloan-Kettering Cancer Center• Organized and directed an expert advisory board with academic oncology Key Opinion Leaders to identify educational content focus. • Leveraged existing and new relationships with NCI Cancer Cooperative Groups and key oncology organizations (ASCO, Lance Armstrong Foundation) to engage key oncology stakeholders and identify high priority education topics. Show less

Responsibilities included communications and liaison activities associated with manuscript submissions, reviewers’ critiques, and editorial correspondence employing a sophisticated database management system from submission to publication.

Led a highly functional Medical Science Liaison (MSL) team leveraging their scientific and medical expertise to support approved product portfolio and new products in development.• Lead, managed, and mentored 6 regionally based MSLs.• Directed the successful team review and implementation of 150 investigator sponsored trials, activated within budget, plan and schedule milestones.• Maintained group compliance with all relevant company, industry, legal and regulatory… Show more Led a highly functional Medical Science Liaison (MSL) team leveraging their scientific and medical expertise to support approved product portfolio and new products in development.• Lead, managed, and mentored 6 regionally based MSLs.• Directed the successful team review and implementation of 150 investigator sponsored trials, activated within budget, plan and schedule milestones.• Maintained group compliance with all relevant company, industry, legal and regulatory requirements.• Facilitated the dissemination of field data and competitive intelligence to internal team.• Expanded group capability; recruited, hired and trained 3 additional MSLs.• Provided operational review updates and program progress through oral presentations and online tracking system.• Integrated and mentored two individual MSL groups through a corporate merger maintaining stable group performance and desired staff retention. Show less

Formulated the initial MSL team including territory alignments, job descriptions, hiring and training. Projected and proposed resource requirements and return on investment (ROI) for MSL capability.• Created initial functional process, including SOP development, for the IST program; protocol review board, study implementation process, national study tracking system, and budgetary accountability parameters for US program.

Identified and built asthma and oncology disease management programs in partnership with insurers and health care providers to support best practice and appropriate clinical use of Schering oncology products.

Expanded project management group capability by adding 5 project managers to initiate and manage over 100 Investigator Sponsored Trials. Responsible for a three million dollar budget which financed programs providing a minimum 100% return on investment.

Directed the planning and development of the Project Management group, responsible for strategy and implementation of national Expanded Clinical Access Program.• Cultivated relationships with Key Opinion Leaders through the development of research initiatives and product presentations.• Nominated for the President’s Award and promoted to senior project manager 1990.

Prepared and presented oncology audience development and sales training programs.

Managed multi-centered oncology clinical trials with biological agents including alpha interferon, GM-CSF and IL-6.

Developed relationships with key hospitals, pharmaceutical and medical device companies. Identified potential advertising opportunities correlated with journal editorial content.

Responsibilities included patient enrollment, consent, sample collection and data management for clinical research studies assessing complement immune function in cancer patients.

Prepared and administered chemotherapy and monitored patients during treatment in a high volume outpatient clinical setting. Most patients participated in NCI research studies.

Provided care for pediatric patients on a combined medical and surgical unit, focused on cardiac repairs.